PDF(260 KB)
PDF(260 KB)
PDF(260 KB)
Assessing the effect of removing human cytomegalovirus from blood
components using quantitative polymerase chain reaction
The purpose of the current study is to assess the effect of removing human cytomegalovirus ( HCMV) by leukocyte reduction filtration ( LRF) in blood center. Peripheral blood mononuclear cells ( PBMCs) from blood
samples negative for HCMV-IgG and pp65 were separated and co-cultured with HCMV-infected human fibroblasts in order to establish infection. The infected PBMCs were purified from fibroblasts by double selection using magnetic beads coated with anti-human fibroblast antibodies and anti-CD45 and then spiked into whole blood units prior to LRF. After LRF, HCMV load in whole blood and in fibroblasts was assessed using real-time quantitative polymerase chain reaction( PCR) for HCMV DNA and quantitative reverse transcriptase PCR( RT-PCR) for mRNA encoding the
HCMV DNA and fibroblast-specific splice variant of prolyl-4-hydroxylase, respectively. After LRF, the rate of leukocyte depletion in whole blood units ( 200 ml) was 99. 98%. After correcting for fibroblast-associated HCMV, the mean HCMV load in whole blood was reduced from3 742 to 22. 57 copies per microliter ( 2. 50 log10 reduction) by LRF. These results suggest that LRF reduces viral load but does not completely remove HCMV from blood components.
Human cytomegalovirus / Leukocyte reduction filtration(LRF) / Fibroblast
PDF(260 KB)
/
| 〈 |
|
〉 |